Delivery Order SPE2DB24D2109-SPE2DB25FHXRB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,027.44 for Fycompa 8 mg tablets (30-count) with an ultimate completion date of September 5, 2025. This competitive delivery order, issued under firm fixed-price terms with no set-aside designation, represents a single pharmaceutical supply transaction fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for the supply of Fycompa (perampanel) 4 mg tablets in a 30-count quantity, with a contract value of $1,033.98 and a firm fixed price structure. The award, issued on September 22, 2025, with completion scheduled for September 23, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,524.73 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition for this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,072.56 to AmerisourceBergen Drug Corp for 30 tablets of Fycompa 6 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Fycompa is an antiepileptic medication used to treat partial-onset seizures, reflecting AmerisourceBergen's role...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fycompa 8 mg tablets (30-count) with a ceiling value of $1,417.05. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.95 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Fycompa 0.5 mg/ml oral suspension in a 340 ml unit. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Fycompa 8 mg tablets (30-count units) with a ceiling value of $1,713.96. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government. The award was made without a set-aside designation, indicating open competition. The performance location is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,148.08 by the Defense Logistics Agency on August 5, 2025, for the supply of Fycompa 4 mg tablets (30-count). This firm fixed-price delivery order, which concludes on August 6, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,111.20 to AmerisourceBergen Drug Corp for the supply of Fycompa 4 mg tablets (30-count units) on July 10, 2025, with completion scheduled for July 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Fycompa 2 mg tablets (30-count packaging) with a contract ceiling value of $1,637.80. This firm fixed-price delivery order, which carries an ultimate completion date of September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award required no set-aside designation and will be...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXRBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,090.14 to AmerisourceBergen Drug Corp for Fycompa 10 mg tablets (30-count package) on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order represents a non-competitive award executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a strategic position as a prime vendor within the DLA's medical supply chain. As a child contract stemming from the larger SPE2DX vehicle, this delivery order exemplifies the routine pharmaceutical procurement operations supporting military healthcare programs and the Defense Health Agency. The award demonstrates AmerisourceBergen's capability to deliver specialized medications, including neurological treatments like Fycompa (perampanel), across the federal healthcare system through flexible contract mechanisms designed to ensure rapid medical supply availability to military and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/7/25 |